SynBio: unlocking the commercial potential of a new bioscience industry
An exclusive column from the ABPI's Magda Papadaki about the implications of synthetic biology for the pharmaceutical industry...
List view / Grid view
Articles
Is high resolution mass spectrometry the missing piece in continuous bioproduction?
Consistent with quality-by-design (QbD), and driven by the desire for continuous manufacture and real-time lot release, biopharmaceutical manufacturers require advanced process analytical technologies (PAT) for process monitoring and rapid analytical information generation.
The people factor: investigating the gown
An effective environmental monitoring programme is designed to estimate the microbial content of the room’s air and surfaces (by incident rate, against alert and action levels, and by assessment of different species) for operations performed within a cleanroom or controlled environment.
Life sciences moves to unify clinical operations to improve study quality
Veeva's Rik Van Mol explains how streamlining the clinical process will not only improve the speed but also the quality of the data...
Innovation with a purpose at Agilent
David Edwards explains how Agilent spectroscopy systems combine core qualities of robustness and reliability with a spirit of innovation.
How thermal fluid maintenance maximises productivity
Global Heat Transfer's MD, Clive Jones, gives 3 considerations for manufacturers operating thermal fluid heat transfer systems to safeguard the system’s future for the long term.
Drug and alcohol testing: An expanding market
The demand for drug and alcohol testing in the UK is at an all-time high and the market is growing rapidly, says Livingstone's Barry Sheehan...
Supply chains key to Life Sciences transformation, says new report
Life Sciences and Healthcare supply chains need transformation to support the increasing cost pressures and consumer demands for new and more convenient, affordable care models…
Outsourcing: Current trends in the CDMO sector
Patheon’s Joe Principe examines current trends in outsourcing, highlighting the importance of investment in CDMO partnerships...
Separations & Purifications In-Depth Focus 2017
In this Separations & Purifications In-Depth Focus: Experts from Leo Pharma explain how they use an MHC 2D-LC system in their analytical troubleshooting laboratory and how it can be applied to solve key tasks in the lab. Plus, Dave Elder explains how guidance for mutagenic impurities has necessitated control of…
Looking for life sciences opportunities in a post-Brexit world – part 2
A year on from the Brexit referendum, Dr Penny Owen outlines the potential risks this vote could have on the life science industry and how to prepare for leaving the EU...
Freeze-dried formulations: a new perspective on reformulating naloxone
Opioid overdose in the US and in Europe is on the rise, and the role of prescription-sourced drugs such as oxycodone cannot be underestimated...
Raman spectroscopy as a blood glucose monitoring tool
European Pharmaceutical Review, Issue 2 of 2016 focused on nanotechnology and stem cell technology to monitor glucose and prevent diabetes, respectively. The aim of this review is to sensitise the technology innovators in this field by providing expert opinions on biomedical products and technologies that have come the closest so…
Raman Spectroscopy In-Depth Focus
In this Raman Spectroscopy In-Depth Focus: Subvisible particle identification in protein-based formulations by Raman spectroscopy; Raman spectroscopy as a blood glucose monitoring tool...
The regulatory acceptance of rapid microbiological methods
In the last issue of European Pharmaceutical Review (vol 22, issue 2), Jeanne Moldenhauer suggested the pharmaceutical industry has moved at a “snail’s pace” in terms of implementing rapid microbiological methods (RMM).
